Yogurt, which contains live strains of bacteria, is thought to protect against many types of diseases, with some reports indicating…
Read More »Colorectal
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…
Read More »Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer…
Read More »